机器人辅助腔内经直肠MRI引导活检诊断前列腺癌:57例患者分析
研究纳入57例双参数MRI可见单发前列腺病灶患者,行机器人辅助经直肠MRI引导活检,技术成功率为100%,总体肿瘤检出率为67%(38/57),无并发症,MRI室占用时间中位数37.8±9.7分钟,使用1-2针芯即可获得高检出率。
要点
- 机器人辅助经直肠MRI引导活检技术成功率100%,所有病灶针导引均与目标对齐。
- 总体肿瘤检出率67%(38/57),Gleason分级>3或最大癌芯长度>3mm肿瘤检出率95%(36/38)。
- 取超过2针芯对Gleason评分或最大癌芯长度无增量价值,1-2针芯即可。
核心结论
- 机器人辅助MRI引导活检技术成功率达100%,MRI室占用时间短,使用1或2针芯即可获得高肿瘤检出率。
研究设计与样本
- 单中心前瞻性可行性分析纳入57例双参数MRI(T2加权和扩散加权成像)可见单发前列腺病灶患者,平均年龄67±6岁(范围57-83岁),平均前列腺特异性抗原水平10.7±6.1 ng/mL,行机器人辅助经直肠MRI引导活检。
关键影像表现/征象
- 双参数MRI评分3、4、5分者分别为11例(19%)、30例(53%)、16例(28%)。
- 病灶位于外周带23个(23/57,40%),位于移行带34个(34/57,60%)。
- 活检针芯数为1、2、3、4针者分别为1例(2%)、36例(63%)、18例(32%)、3例(5%)。
诊断标准与关键数值
- 技术成功定义为针导引与病灶精确对齐,本组所有病灶均实现对齐,技术成功率100%。
- 总体任何肿瘤检出率为67%(38/57)。
- Gleason分级>3或最大癌芯长度>3mm的肿瘤检出率为95%(36/38),Gleason评分>6的肿瘤检出率为53%(20/38)。
- 取超过2针芯对Gleason评分或最大癌芯长度无增量价值。
- MRI室占用时间中位数37.8±9.7分钟(范围32-74分钟),无并发症发生。
临床应用与阅片要点
- 机器人辅助经直肠MRI引导活检可用于双参数MRI可见单发前列腺病灶的诊断,技术成功率高且无并发症。
- 采用1或2针芯即可获得高肿瘤检出率,取超过2针芯对Gleason评分或最大癌芯长度无增量价值。
- MRI室占用时间中位数37.8±9.7分钟,操作流程可行。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE. The objective of our study was to analyze the feasibility and potential role of robotic-assisted transrectal MRI-guided biopsy for the diagnosis of prostate cancer. MATERIALS AND METHODS. A total of 57 patients (mean age, 67 ± 6 [SD] years; age range, 57-83 years; mean prostate-specific antigen level, 10.7 ± 6.1 ng/mL) with a single prostatic lesion visible on biparametric MRI (T2-weighted and DW images) underwent robotic-assisted MRI-guided transrectal biopsy. The procedure was analyzed in terms of technical success, defined by an accurate alignment of the needle guide with the lesion; occupation time of the MRI room; number of cores; cancer detection rate (CDR); and complications. RESULTS. The biparametric MRI score was 3, 4, and 5 in 11 (19%), 30 (53%), and 16 (28%) of the 57 patients, respectively. Twenty-three lesions (23/57, 40%) originated in the peripheral zone and 34 (34/57, 60%) in the transition zone. Software-based adjustments of the robot allowed the needle guide to be aligned with the target in all lesions. The number of cores was one, two, three, and four in one (2%), 36 (63%), 18 (32%), and three (5%) patients, respectively. Obtaining more than two cores had no incremental value in determining the Gleason score or the maximum cancer core length (MCCL). The overall CDR for any cancer was 67% (38/57). It was 95% (36/38) for tumors with Gleason grade of more than 3 or MCCL greater than 3 mm and 53% (20/38) for tumors with Gleason score greater than 6. No complications were observed. The median occupation time of the MRI room was 37.8 ± 9.7 minutes (range, 32-74 minutes). CONCLUSION. Robotic-assisted MRI-guided biopsy yields 100% technical success rate with a short MRI room occupation time and high CDRs using one or two cores.
引用
- Barral M, Lefevre A, Camparo P, et al. In-Bore Transrectal MRI-Guided Biopsy With Robotic Assistance in the Diagnosis of Prostate Cancer: An Analysis of 57 Patients. AJR Am J Roentgenol. 2019. PMID: 31268734. doi:10.2214/AJR.19.21145
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。